Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cremer

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Nature|August 15, 2003
In situ experimental evidence of the fate of a phytodetritus pulse at the abyssal sea floorU Witte, F Wenzhöfer, S Sommer, et al.
Cancers|June 26, 2026
Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer ImmunotherapyJohn W Figg, Julian Mark, Caretia J Washington, et al.
Clinical Immunology and Immunopathology|March 1, 1996
Variable-region gene family usage for type II collagen autoantibodies in arthritis-susceptible DBA/1 miceX J Ye, T N Marion, K Terato, et al.
Acta Gastro-Enterologica Belgica|April 2, 2020
Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)C Reenaers, A Cremer, O Dewit, et al.
Acta Gastro-Enterologica Belgica|August 30, 2024
SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infectionA Hoyois, C Gulkilik, L Mekkaoui, et al.
Plos One|March 15, 2017
Oesophageal heat exchangers with a diameter of 11mm or 14.7mm are equally effective and safe for targeted temperature managementDaniel C Schroeder, Maria Guschlbauer, Alexandra C Maul, et al.
Arthritis and Rheumatism|June 12, 1999
Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritisK M McKown, L D Carbone, S B Kaplan, et al.
British Journal of Clinical Pharmacology|October 18, 2022
Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studiesXin Hui S Chan, Palang Chotsiri, Rebecca A Capel, et al.
Immunology|January 20, 1999
Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 miceL K Myers, D D Brand, X J Ye, et al.
Acta Gastro-Enterologica Belgica|October 13, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab ExposureA Cremer, A Mansour, T Lobaton, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Nature|August 15, 2003
In situ experimental evidence of the fate of a phytodetritus pulse at the abyssal sea floorU Witte, F Wenzhöfer, S Sommer, et al.
Cancers|June 26, 2026
Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer ImmunotherapyJohn W Figg, Julian Mark, Caretia J Washington, et al.
Clinical Immunology and Immunopathology|March 1, 1996
Variable-region gene family usage for type II collagen autoantibodies in arthritis-susceptible DBA/1 miceX J Ye, T N Marion, K Terato, et al.
Acta Gastro-Enterologica Belgica|April 2, 2020
Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)C Reenaers, A Cremer, O Dewit, et al.
Acta Gastro-Enterologica Belgica|August 30, 2024
SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infectionA Hoyois, C Gulkilik, L Mekkaoui, et al.
Plos One|March 15, 2017
Oesophageal heat exchangers with a diameter of 11mm or 14.7mm are equally effective and safe for targeted temperature managementDaniel C Schroeder, Maria Guschlbauer, Alexandra C Maul, et al.
Arthritis and Rheumatism|June 12, 1999
Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritisK M McKown, L D Carbone, S B Kaplan, et al.
British Journal of Clinical Pharmacology|October 18, 2022
Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studiesXin Hui S Chan, Palang Chotsiri, Rebecca A Capel, et al.
Immunology|January 20, 1999
Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 miceL K Myers, D D Brand, X J Ye, et al.
Acta Gastro-Enterologica Belgica|October 13, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab ExposureA Cremer, A Mansour, T Lobaton, et al.
Pageof 9